Sevoflurane Remifentanil Interaction: Comparison of Different Response Surface Models

• Published in: Anesthesiology (Philadelphia) Vol. 116; no. 2; pp. 311 - 323
• Main Authors: HEYSE, Bjorn, PROOST, Johannes H, SCHUMACHER, Peter M, BOUILLON, Thomas W, VEREECKE, Hugo E. M, ELEVELD, Douglas J, LUGINBÜHL, Martin, STRUYS, Michel M. R. F
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 01.02.2012
• Subjects: Adult; Anesthesia; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Anesthetics, Inhalation - administration & dosage; Anesthetics, Inhalation - metabolism; Anesthetics, Intravenous - administration & dosage; Anesthetics, Intravenous - metabolism; Biological and medical sciences; Drug Interactions - physiology; Drug Synergism; Female; Humans; Male; Medical sciences; Methyl Ethers - administration & dosage; Methyl Ethers - metabolism; Models, Biological; Piperidines - administration & dosage; Piperidines - metabolism; Prospective Studies; Young Adult; Volatile compound; Agonist; μ Opioid receptor; Opiates; Narcotic analgesic; Remifentanil; Sevoflurane; General anesthetic; Anesthesia; Phenylpiperidine derivatives; Sedative; Comparative study; Halogen Organic compounds
• ISSN: 0003-3022; 1528-1175
• DOI: 10.1097/ALN.0b013e318242a2ec

Various pharmacodynamic response surface models have been developed to quantitatively describe the relationship between two or more drug concentrations with their combined clinical effect. We examined the interaction of remifentanil and sevoflurane on the probability of tolerance to shake and shout, tetanic stimulation, laryngeal mask airway insertion, and laryngoscopy in patients to compare the performance of five different response surface models. Forty patients preoperatively received different combined concentrations of remifentanil (0-12 ng/ml) and sevoflurane (0.5-3.5 vol.%) according to a criss-cross design (160 concentration pairs, four per patient). After having reached pseudosteady state, the response to shake and shout, tetanic stimulation, laryngeal mask airway insertion, and laryngoscopy was recorded. For the analysis of the probability of tolerance, five different interaction models were tested: Greco, Reduced Greco, Minto, Scaled C50(O) Hierarchical, and Fixed C50(O) Hierarchical model. All calculations were performed with NONMEM VI (Icon Development Solutions, Ellicott City, MD). The pharmacodynamic interaction between sevoflurane and remifentanil was strongly synergistic for both the hypnotic and the analgesic components of anesthesia. The Greco model did not result in plausible parameter estimates. The Fixed C50(O) Hierarchical model performed slightly better than the Scaled C50(O) Hierarchical and Reduced Greco models, whereas the Minto model fitted less well. We showed the importance of exploring various surface model approaches when studying drug interactions. The Fixed C50(O) Hierarchical model fits our data on sevoflurane remifentanil interaction best and appears to be an appropriate model for use in hypnotic-opioid drug interaction.